Clinical Trials

Clinical Trial Detail

Return to search results.

Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012)

Complete title: A Phase Ib Multi-Cohort Study of MK-3475 in Subjects with Advanced Solid Tumors

Research Study Number       20130878
Principal Investigator       Laura Chow
Phase       I

Look up trial at NIH

Research Study Description

This study is being done to investigate the safety, tolerability and anti-tumor activity of MK-3475 in participants with advanced triple negative breast cancer (TNBC), advanced head and neck cancer, advanced urothelial cancer, or advanced gastric cancer.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number       20130878
Contact       Seattle Cancer Care Alliance Intake Office
Telephone       800-804-8824 / 206-288-1024

Bladder Cancer; Breast Cancer; Head and Neck Cancer; Solid Tumors; Urethral Cancer

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials